217 related articles for article (PubMed ID: 30837421)
21. Apparent diffusion coefficient values and dynamic contrast enhancement patterns in differentiating seminomas from nonseminomatous testicular neoplasms.
Tsili AC; Sylakos A; Ntorkou A; Stavrou S; Astrakas LG; Sofikitis N; Argyropoulou MI
Eur J Radiol; 2015 Jul; 84(7):1219-26. PubMed ID: 25937261
[TBL] [Abstract][Full Text] [Related]
22. [Positron emission tomography with [18 F]-2-fluoro-2-deoxy-D-glucose (18FDG-PET) in diagnosis of retroperitoneal lymph node metastases of testicular tumors].
Müller-Mattheis V; Reinhardt M; Gerharz CD; Fürst G; Vosberg H; Müller-Gärtner HW; Ackermann R
Urologe A; 1998 Nov; 37(6):609-20. PubMed ID: 9887489
[TBL] [Abstract][Full Text] [Related]
23. Surgical outcomes in patients with primary mediastinal non-seminomatous germ cell tumours and elevated post-chemotherapy serum tumour markers.
De Latour B; Fadel E; Mercier O; Mussot S; Fabre D; Fizazi K; Dartevelle P
Eur J Cardiothorac Surg; 2012 Jul; 42(1):66-71; discussion 71. PubMed ID: 22290909
[TBL] [Abstract][Full Text] [Related]
24. Nonseminomatous germ cell tumors: enlarging masses despite chemotherapy.
Panicek DM; Toner GC; Heelan RT; Bosl GJ
Radiology; 1990 May; 175(2):499-502. PubMed ID: 2158120
[TBL] [Abstract][Full Text] [Related]
25. Does the Serum Metallothionein Level Reflect the Stage of Testicular Germ Cell Tumor?
Tariba B; Živković T; Filipović Marijić V; Erk M; Gamulin M; Pizent A
Arch Med Res; 2016 Apr; 47(3):232-5. PubMed ID: 27255355
[TBL] [Abstract][Full Text] [Related]
26. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
Beck SD; Foster RS; Bihrle R; Donohue JP
Urology; 2007 Mar; 69(3):557-9. PubMed ID: 17382165
[TBL] [Abstract][Full Text] [Related]
27. Testicular seminoma with human chorionic gonadotropin production.
Hori K; Uematsu K; Yasoshima H; Yamada A; Sakurai K; Ohya M
Pathol Int; 1997 Sep; 47(9):592-9. PubMed ID: 9311009
[TBL] [Abstract][Full Text] [Related]
28. The role of alkaline phosphatase isoenzymes as tumor markers for testicular germ cell tumors.
Koshida K; Nishino A; Yamamoto H; Uchibayashi T; Naito K; Hisazumi H; Hirano K; Hayashi Y; Wahren B; Andersson L
J Urol; 1991 Jul; 146(1):57-60. PubMed ID: 1711586
[TBL] [Abstract][Full Text] [Related]
29. Prostatic metastases from testicular nonseminomatous germ cell cancer: two case reports and a review of the literature.
Torelli T; Lughezzani G; Catanzaro M; Nicolai N; Colecchia M; Biasoni D; Piva L; Maffezzini M; Stagni S; Necchi A; Giannatempo P; Farè E; Salvioni R
Tumori; 2013; 99(5):e203-7. PubMed ID: 24362870
[TBL] [Abstract][Full Text] [Related]
30. Serum lactate dehydrogenase isoenzyme 1. An early indicator of relapse in patients with testicular germ cell tumors.
Edler von Eyben F; Lindegaard Madsen E; Blaabjerg O; Hyltoft Petersen P
Acta Oncol; 1995; 34(7):925-9. PubMed ID: 7492382
[TBL] [Abstract][Full Text] [Related]
31. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
[TBL] [Abstract][Full Text] [Related]
32. Extragonadal and poor risk nonseminomatous germ cell tumors. Survival and prognostic features.
Toner GC; Geller NL; Lin SY; Bosl GJ
Cancer; 1991 Apr; 67(8):2049-57. PubMed ID: 1848473
[TBL] [Abstract][Full Text] [Related]
33. Is gynecomastia related to the disease characteristics and prognosis in testicular germ cell tumor patients?
Polat AV; Öztürk M; Çamlıdağ İ; Akyüz B
Diagn Interv Radiol; 2019 May; 25(3):189-194. PubMed ID: 31063146
[TBL] [Abstract][Full Text] [Related]
34. Germ cell tumours: a scary presentation.
Oliveira CAB; Costa AC; Mendes V
BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32699054
[No Abstract] [Full Text] [Related]
35. Platinum-based chemotherapy of primary extragonadal germ cell tumours: the Hellenic Cooperative Oncology Group experience.
Pectasides D; Aravantinos G; Visvikis A; Bakoyiannis C; Halikia A; Kalofonos C; Kosmidis P; Skarlos D; Fountzilas G
Oncology; 1999 Jul; 57(1):1-9. PubMed ID: 10394118
[TBL] [Abstract][Full Text] [Related]
36. Giant testicular seminoma.
Ellimoottil C; Quek ML
Urology; 2012 Oct; 80(4):e35-6. PubMed ID: 22901819
[TBL] [Abstract][Full Text] [Related]
37. The potential role of MR based radiomic biomarkers in the characterization of focal testicular lesions.
Feliciani G; Mellini L; Carnevale A; Sarnelli A; Menghi E; Piccinini F; Scarpi E; Loi E; Galeotti R; Giganti M; Parenti GC
Sci Rep; 2021 Feb; 11(1):3456. PubMed ID: 33568713
[TBL] [Abstract][Full Text] [Related]
38. CT findings of primary non-teratomatous germ cell tumors of the mediastinum--a report of 15 cases.
Tian L; Liu LZ; Cui CY; Zhang WD; Kuang YL
Eur J Radiol; 2012 May; 81(5):1057-61. PubMed ID: 21353416
[TBL] [Abstract][Full Text] [Related]
39. When is a Seminoma not a Seminoma? The Incidence, Risk Factors and Management of Patients With Testicular Seminoma With Discordant Elevated Serum Alpha-fetoprotein.
Fero KE; Lec PM; Sharma V; Lenis AT; Low J; Litwin MS; Leapman MS; Chamie K
Urology; 2021 Nov; 157():188-196. PubMed ID: 34389428
[TBL] [Abstract][Full Text] [Related]
40. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
